CYAD - Celyad Oncology reports 1H results
- Celyad Oncology (NASDAQ:CYAD): 1H Net loss of €16.6M.
- More news on: Celyad Oncology SA, Earnings news and commentary, Healthcare stocks news, , Read more ...
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Celyad SA |
| Stock Symbol: | CYAD |
| Market: | NASDAQ |
Get CYAD Alerts
News, Short Squeeze, Breakout and More Instantly...